year 16, Issue 6 (November - December 2022)                   Iran J Med Microbiol 2022, 16(6): 607-608 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sepandi M, Alimohamadi Y. Monkeypox: A Re-emerging Infectious Disease. Iran J Med Microbiol 2022; 16 (6) :607-608
1- Exercise Physiology Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
2- Exercise Physiology Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran ,
Abstract:   (1183 Views)

Monkeypox is a rare zoonotic infectious disease caused by the Monkeypox viruses, a type of Orthopoxvirus of the family Poxviridae, which is endemic to Africa. Monkeypox, which is usually a self-limiting illness, starts with flu-like symptoms (fever, muscle aches, chills, and fatigue). Usually, within 1 to 3 days (sometimes longer) after the onset of fever, the patient develops a rash that often starts on the face and then spreads to other parts of the body. Lesions may appear all over the body. Decreased immunity of populations due to the cessation of smallpox vaccination in the past, has paved the way for Monkeypox. This is shown by the increase in the number of cases as well as the recurrence of the disease in some countries. Due to the importance of the Monkeypox and the limited number of Persian language sources in this regard, the present article aimed to introduce this disease as a zoonotic infectious disease that has recently, been reported in several countries.

Full-Text [PDF 350 kb]   (333 Downloads) |   |   Full-Text (HTML)  (392 Views)  
Type of Study: Letter to the Editor | Subject: Medical Virology
Received: 2022/05/23 | Accepted: 2022/07/17 | ePublished: 2022/09/9

1. Magnus Pv, Andersen EK, Petersen KB, Birch‐Andersen A. A pox‐like disease in cynomolgus monkeys. Acta Pathol Microbiol Scand A. 1959;46(2):156-76. [DOI:10.1111/j.1699-0463.1959.tb00328.x]
2. Breman J, Kalisa-Ruti M, Zanotto E, Gromyko A, Arita I. Human monkeypox, 1970-79. Bull World Health Organ. 1980;58(2):165.
3. Yinka-Ogunleye A, Aruna O, Ogoina D, Aworabhi N, Eteng W, Badaru S, et al. Reemergence of human monkeypox in Nigeria, 2017. Emerg Infect Dis. 2018;24(6):1149. [DOI:10.3201/eid2406.180017] [PMID] [PMCID]
4. CDC. Monkeypox 2022 [cited 2022 22/05/2022]. 2022.
5. ECfDPaC E. Epidemiological update: Monkeypox outbreak 2022 [22/05/2022]. 2022.
6. Breman JG, Henderson DA. Diagnosis and management of smallpox. New Eng J Med. 2002;346(17):1300-8. [DOI:10.1056/NEJMra020025] [PMID]
7. Organization W. Monkeypox [22/05/2022]. 2022.
8. CDC. Monkeypox and Smallpox Vaccine Guidance 2022 [22/05/2022]. 2022.
9. Pittman PR, Hahn M, Lee HS, Koca C, Samy N, Schmidt D, et al. Phase 3 efficacy trial of modified vaccinia Ankara as a vaccine against smallpox. New Eng J Med. 2019;381(20):1897-908. [DOI:10.1056/NEJMoa1817307] [PMID]
10. CDC. Infection Control: Hospital 2022 [23/05/2022]. 2022.
11. CDC. Interim Clinical Guidance for the Treatment of Monkeypox 2022 [12/06/2022]. 2022.

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc